Aurobindo Pharma has gained final FDA approval for its generic Nevirapine tablets and oral suspension used for treating human immunodeficiency virus (HIV). The FDA approved Nevirapine tablets of 200mg strength and Nevirapine oral ...
Tags: Aurobindo Pharma, FDA, Nevirapine, HIV drug
Tokyo-based Astellas Pharma’s European subsidiary has announced that it has received marketing authorization from the Netherlands Medicines Evaluation Board (MEB) for Vesomni. The marketing authorization received for Vesomni is ...
Tags: Netherlands Meb, Medicine
Spanish-German biotech company Sygnis Pharma has entered into a licence agreement for the distribution of a new amplification buffer with QIAGEN, a sample and assay technologies provider. This is the second agreement with QIAGEN within ...
Tags: Sygnis Pharma, Buffer to Qiagen
Specialized is offering a limited edition replica frameset to celebrate pro Mark Cavendish's 100th race win. The $3,750 frame set is expected to be in stores as early as next week, the company said. Cavendish, on the Omega Pharma-Quick ...
Roche Group member Genentech and Astellas Pharma US announced that the US Food and Drug Administration (FDA) has cleared Tarceva (erlotinib). The tablets are used for the initial treatment of people with metastatic non-small cell lung ...
Tags: FDA, Tarceva Tablets, Astellas Pharma
Research Solutions's wholly-owned subsidiary Reprints Desk has launched a compliance software-as-a-service (SaaS) solution for medical marketers. Reprints Desk's Sunshine ePrints solution simplifies Sunshine Act compliance for the use of ...
Drug distributor in the US, AmerisourceBergen has completed the previously announced sale of AndersonBrecon's contract packaging business to an investor group headed by Frazier Healthcare Ventures, in a deal worth $308m. The investor ...
Tags: Packaging, AmerisourceBergen
PMMI, owner and producer of the PACK EXPO trade shows, and the International Society for Pharmaceutical Engineering (ISPE) announce the debut of Pharma EXPO, a new event designed to connect pharmaceutical, medical device and nutraceutical ...
UK-based drug discovery and development company Redx Pharma is planning to open a new £10.5m research and development facility at AstraZeneca's Alderley Park site in Cheshire, England. The new venture, Redx Anti-Infectives, will ...
Tags: Redx Pharma, Medicine
Mapi Pharma, developer of complex bulk Active Pharmaceutical Ingredients (APIs), has been granted a US patent for a long acting depot formulation of glatiramer acetate, which is under the development as a once-a-month treatment for Multiple ...
Martindale Pharma has announced the UK launch of Prenoxad injection, the licensed emergency treatment for acute opioid related overdose for use at home or other non-medical settings. Prenoxad Injection is a prescription only medicine ...
ChemRar Ventures has entered into scouting agreement with Sanofi for a venture investment in Russia and Asia. As per the agreement, ChemRar Ventures will source early and late stage compounds within a certain defined area of Sanofi's ...
US-based software company Acsis has introduced the new ‘Serialization in a Box’ solution for pharma industry that identifies, applies and captures the data needed for compliance with California’s upcoming 2015 e-pedigree ...
The pump specialist Flux-Gerte GMBH from Maulbronn has conducted further developments on the highly flexible Viscoflux mobile drum emptying system, with which highly viscous, paste-like, non-flowing materials can be transported continuously ...
Shanghai Fosun Pharma, a China-based company, has announced that it will jointly invest $240m with Pramerica-Fosun China Opportunity Fund to purchase around 95.6% share of Israel-based Alma Lasers. Alma Lasers is a global medical and ...
Tags: Fosun Pharma, Alma Lasers